Data from the Hong Kong Stock Exchange reveals that on August 11, JPMorgan reduced its holdings in PHARMARON (03759) by 953,266 shares, with an average price of HK$29.3257 per share, totaling approximately HK$27.9552 million.
Following the reduction, JPMorgan's latest shareholding in PHARMARON stands at about 28,122,300 shares, representing 7.81% of the total issued shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments